Periodic assessment of (ET-1) and Nitric Oxide (NO) in hypertensive disorders of pregnancy (HDP)

• Main Authors: Ismawi, Hidayatul Radziah, Abdul Razak, Tariq, Jamani, Nurjasmine Aida, Mohd Zainudin, Maizura
• Format: Conference or Workshop Item
• Language: English; English
• Published: 2019
• Subjects: RC Internal medicine; RC667 Specialties of Internal Medicine-Diseases of Circulatory (Cardiovascular) System; RG Gynecology and obstetrics; RG551 Pregnancy
• Online Access: http://irep.iium.edu.my/83592/1/FAOPS%202019%20EDITED%20poster%2090x190cm.pdf; http://irep.iium.edu.my/83592/17/FAOPS2019_Programbook.pdf; http://irep.iium.edu.my/83592/

INTRODUCTION Hypertensive Disorders of Pregnancy (HDP) is an independent risk factor of cardiovascular (CVS) disease. Endothelin-1 (ET-1), a potent vasoconstrictor, has been identified as a pivotal mediator in both essential hypertension and HDP. Disturbances in Nitric Oxide (NO) bioavailability...